Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

top_ten

Top Ten most popular articles on Pharmafile.com this week

April 20, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, EMA, GW Pharma, J&J, JJ, MHRA, Mylan, Novartis, Sanofi, Shire, Takeda, biotech, drugs, epipen, keytruda, pharma, pharmaceutical

It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …
News
shutterstock_244903099

The UK’s Royalties withholding tax consultation: Pushing extraterritorial boundaries

April 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Norton Rose Fulbright, feature, pharma, tax consultation

Norton Rose Fulbright’s Dominic Stuttaford, James Baillieu and Susie Brain discuss the implications regarding the recent reforms to cross-border royalties.The …
Feature
iannone

Immunomedics’ whirlwind in the C-suite continues

April 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …
Appointment
bill_chin_headshot

Frequency Therapeutics hires industry vet

April 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …
Appointment

BMS’ Opdivo+Yervoy combo secures FDA approval in kidney cancer

April 18, 2018 Research and Development, Sales and Marketing BMS, Bristol Myers Swuibb, Cancer, FDA, Yervoy, carcinoma, opdivo, pharma

The FDA has announced its approval of a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), both products from Bristol Myers …
News
epi-pen_1_3

EpiPen shortage hits UK and Canada hard, but not US

April 18, 2018 Research and Development, Sales and Marketing Mylan, Pfizer, biotech, drugs, epipen, pharma, pharmaceutical

Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK …
News
amgen_flag

Amgen and Novartis’ Aimovig shines in migraine at Phase 3

April 18, 2018 Research and Development Aimovig, Amgen, Novartis, migraine, pharma

Amgen has lifted the curtain on complete Phase 3 data for its calcitonin gene-related peptide receptor (CGRP) inhibitor Aimovig (erenumab) in …
News
jerome_contamine_770x510

Sanofi CFO set to step down this year

April 18, 2018 Medical Communications, Research and Development Sanofi, biotech, cfo, drugs, pharma, pharmaceutical

After a busy start to the year, with a number of acquisitions and a few divestments, Sanofi’s Chief Financial Officer, …
News
gw_pharma

All indications point to approval for cannabis-based therapy

April 17, 2018 Research and Development, Sales and Marketing FDA, GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharma are inching step by step towards a likely approval with the FDA, after it received a strong recommendation …
News
novartis_outside_1

Novartis to invest $100m in new malaria treatments

April 17, 2018 Manufacturing and Production, Research and Development Novartis, WHO, malaria, pharma

Novartis has revealed it is to invest $100 million into the research and development of new treatments for malaria over …
News
merckwindow_web

Keytruda success continues, beating Opdivo in lung cancer survival

April 17, 2018 Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

Not content with revealing two strong waves of data on its flagship immunotherapy Keytruda (pembrolizumab) over the past weeks, MSD …
News
pharmacy-3087596_960_720

Care packaging: Inside the Falsified Medicines Directive

April 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, packaging, pharma, pharmaceutical

When it comes to the pharmaceutical supply chain, patient safety has and will always be a primary concern for all …
Feature
novartis_outside_1

Novartis’ Entresto helps preserve kidney function in chronic heart failure patients

April 16, 2018 Research and Development, Sales and Marketing Entresto, Novartis, heart failure, pharma

Novartis has lifted the curtain on new data from a Phase 3 trial investigating the efficacy of Entresto (sacubitril/valsartan) in …
News

J&J’s ketamine nasal spray for depression continues to impress

April 16, 2018 Research and Development, Sales and Marketing Johnson & Johnson, Ketamine, biotech, drugs, pharma, pharmaceutical

New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …
News
merckentranceweb

Keytruda continues success with new Phase 3 data in adjuvant melanoma

April 16, 2018 Research and Development, Sales and Marketing Cancer, MSD, keytruda, melanoma, pharma, skinc cancer

MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026